Scientists have shown for the first time that tumour DNA shed into the bloodstream can be used to track cancers in real time as they evolve and respond to treatment, according to a new Cancer Research UK study published in the journal Nature Communications.
Over three years, researchers at the University of Cambridge took surgical tumour samples (biopsies) and blood samples from a patient with breast cancer that had already spread to other parts of her body. They carefully studied small fragments of DNA from dying tumour cells that are shed into the blood, comparing them with DNA from the biopsy that was taken at the same point in time.
The results show that the DNA in the blood samples matched up with that from the biopsies, reflecting the same pattern and timing of genetic changes appearing as the cancer developed and responded to treatment. The results provide the first proof-of-principle that analysing tumour DNA in the blood can accurately monitor cancer within the body.
Study author Professor Carlos Caldas, senior group leader at the Cancer Research UK Cambridge Institute, said: “This definitively shows that we can use blood-based DNA tests to track the progress of cancer in real time. The findings could change the way we monitor patients, and may be especially important for people with cancers that are difficult to reach, as taking a biopsy can sometimes be quite an invasive procedure.”
The patient in the study had breast cancer that had already spread to a number of other organs. The researchers – part of a collaborative team effort involving the Carlos Caldas and Nitzan Rozenfeld laboratories at the Cancer Research UK Cambridge Institute – were even able to distinguish between the different secondary cancers and examine how each of the tumours was responding to treatment.
Professor Caldas added: “We were able to use the blood tests to map out the disease as it progressed. We now need to see if this works in more patients and other cancer types, but this is an exciting first step.”
Read more: DNA in blood can track cancer development and response in real time
The Latest on: Track cancer development
[google_news title=”” keyword=”Track cancer development” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Track cancer development
- National Cancer Research Month: 7 CU Boulder discoveries that could improve, save liveson May 8, 2024 at 10:03 am
From developing new therapies to help patients cope with anxiety to discovering new ways to treat resistant breast cancer and new environmentally friendly methods for producing chemotherapy drugs, CU ...
- Unraveling the complex pathology of gastric cancer: TP53 loss and extrinsic risk factorson May 7, 2024 at 10:14 pm
GC ranks as the fifth most common and fourth deadliest cancer worldwide, presenting significant health challenges, particularly in China where it is most prevalent and accounts for nearly half of ...
- CG Oncology Touts Bladder Cancer Complete Response Rate for Immunotherapyon May 6, 2024 at 6:50 am
Following an upsized IPO earlier this year, CG Oncology on Friday posted promising Phase III data for cretostimogene, which elicited a 75% complete response rate in high-risk non-muscle invasive ...
- HIFU for Treatment of Prostate Canceron May 5, 2024 at 9:52 pm
Prostate cancer poses a significant health concern in India, with 33,000-42,000 new cases annually. A recent Lancet report has warned of a sharp surge in cases in India by 2040, with many men being ...
- Tech can improve cancer supportive care, but it takes training to use it effectivelyon May 4, 2024 at 5:00 pm
Digital health technology – including smartphone apps and wearable devices – can help extend the reach of cancer clinicians and improve the quality of supportive care for cancer patients. But using ...
- Cancer fight is a walk around the clockon May 4, 2024 at 5:00 pm
Hundreds gathered Saturday for the 33rd Bakersfield Relay for Life, a 24-hour walk around the track at the Kern County ... with most of the money slated for cancer research, said Donna Hermann, a ...
- Lung cancer study enrolling participants to research inherited riskon April 28, 2024 at 11:06 pm
As a growing number of never-smokers are being diagnosed with lung cancer, new research aims to better understand the genetic risk, or predisposition, for developing lung cancer — and study ...
- FDA Grants Fast Track Designation to CTX-009 in Biliary Tract Canceron April 26, 2024 at 12:00 pm
“is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important new drugs to the ...
- Polish immigrant on terminal cancer diagnosis: ‘This is one of the best years of my life’on April 26, 2024 at 3:00 am
Max Savar, who helps lead the YMCA of Greater Charlotte’s Harris branches, has become obsessed with tackling long-distance triathlon and colon cancer.
- Can vitamin D help fight cancer?on April 25, 2024 at 9:45 pm
When his colleague Evangelos Giampazolias, now at the Cancer Research UK Manchester Institute, discovered that switching off the gene which provides instructions to make the aptly named vitamin ...
via Bing News